← All organizations
Highest phase reached
Phase 1
First clinical trial
Mar 11, 2017Last known activity
Apr 30, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT04352803Lead sponsorPhase 1Apr 30, 2020
- NCT03090672Lead sponsorN/AMar 11, 2017
- NCT03090672Overall official - principal investigatorN/AMar 11, 2017
- NCT03090672Sponsor investigatorN/AMar 11, 2017
- NCT03090672CollaboratorN/AMar 11, 2017
Details
- Last known activity
- Apr 30, 2020